Crossject Société Anonyme (EPA:ALCJ)
France · Delayed Price · Currency is EUR 1.972
-0.118 (-5.65%)
Jun 3, 2026, 5:35 PM CET
Crossject Société Anonyme Market Cap
Crossject Société Anonyme has a market cap or net worth of €113.79 million as of June 3, 2026. Its market cap has increased by 39.62% in one year.
Market Cap
113.79M
Enterprise Value
131.16M
Revenue
2.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.97
Market Cap Chart
Since February 20, 2014, Crossject Société Anonyme's market cap has increased from 59.40M to 113.79M, an increase of 91.56%. That is a compound annual growth rate of 5.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 113.79M | -1.48% |
| Dec 31, 2025 | 115.50M | 10.53% |
| Dec 31, 2024 | 104.50M | -44.71% |
| Dec 29, 2023 | 188.99M | 90.83% |
| Dec 30, 2022 | 99.04M | 26.25% |
| Dec 31, 2021 | 78.44M | 0.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 89.01B |
| EssilorLuxottica Société anonyme | 79.44B |
| Sartorius Stedim Biotech | 17.27B |
| Ipsen | 12.46B |
| Innate Pharma | 148.63M |
| Guerbet | 131.95M |
| Euroapi | 130.41M |
| ABIONYX Pharma | 98.82M |